Evidence map›Paper›PMID 8739224›Full record

ReviewMolecular and cellular biochemistry

Angiotensin II signalling pathways in cardiac fibroblasts: conventional versus novel mechanisms in mediating cardiac growth and function.

D E Dostal, G W Booz, K M Baker

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular and cellular biochemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Range of adiposity and cardiorenal syndrome.World journal of diabetes · 2020
    Review
  3. Article
  4. Mechanosensing and Regulation of Cardiac Function.Journal of clinical & experimental cardiology · 2014
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

D E DostalWeis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822, USA.
G W Booz
K M Baker
Geisinger Medical Center · US

Funding

REGULATION OF CARDIAC HYPERTROPHY BY ANGIOTENSINSR01HL044883 · NHLBI · WEIS CENTER FOR RESEARCH-GEISINGER CLINC · PI BAKER, KENNETH MELVIN · 1990 to 2002
$801k
REGULATION OF CARDIAC SECOND MESSENGERS BY ANGIOTENSINR01HL044379 · NHLBI · WEIS CENTER FOR RESEARCH-GEISINGER CLINC · PI BAKER, KENNETH MELVIN · 1991 to 1993
–
NHLBI NIH HHS HL44379NHLBI NIH HHS HL44883
6 · The paper itself

Abstract

Angiotensin II has been demonstrated to be involved in the regulation of cellular growth of several tissues in response to developmental, physiological, and pathophysiological processes. Angiotensin II has been implicated in the developmental growth of the left ventricle in the neonate and remodeling of the heart following chronic hypertension and myocardial infarction. The inhibition of DNA synthesis and collagen deposition in myocardial interstitium following myocardial infarction by angiotensin converting enzyme inhibitor, suggests that angiotensin II mediates interstitial and perivascular fibrobrosis by preventing fibroblast proliferation. In the past, little attention was focused on the identity and functional roles of cardiac fibroblasts. Recent in vitro studies utilizing cultured cardiac fibroblasts demonstrate that angiotensin II, acting via the AT1 receptor, initiates intracellular signalling pathways in common with those of peptide growth factors. Below, we describe growth-related aspects of cardiac fibroblasts with respect to angiotensin II receptors, conventional and novel signal transduction systems, secretion of extracellular matrix proteins and growth factors, and localization of renin-angiotensin system components.

Indexed as

Signal TransductionAngiotensin IIAnimalsCytokinesExtracellular MatrixFibroblastsGrowth SubstancesHeartHumansHypertensionInfant, NewbornMyocardial InfarctionMyocardiumProtein Kinase CAngiotensin IICytokinesGrowth SubstancesProtein Kinase C

Identifiers

PMID8739224
OpenAlexW1965524726

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.